Abstract:Pyroptosis is the process of inflammatory cell death. The primary function of pyroptosis is to induce strong inflammatory responses that defend the host against microbe infection. Excessive pyroptosis, however, leads to several inflammatory diseases, including sepsis and autoimmune disorders. Pyroptosis can be canonical or noncanonical. Upon microbe infection, the canonical pathway responds to pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs), while the noncanonical pathway responds to intracellular lipopolysaccharides (LPS) of Gram-negative bacteria. The last step of pyroptosis requires the cleavage of gasdermin D (GsdmD) at D275 (numbering after human GSDMD) into N- and C-termini by caspase 1 in the canonical pathway and caspase 4/5/11 (caspase 4/5 in humans, caspase 11 in mice) in the noncanonical pathway. Upon cleavage, the N-terminus of GsdmD (GsdmD-N) forms a transmembrane pore that releases cytokines such as IL-1β and IL-18 and disturbs the regulation of ions and water, eventually resulting in strong inflammation and cell death. Since GsdmD is the effector of pyroptosis, promising inhibitors of GsdmD have been developed for inflammatory diseases. This review will focus on the roles of GsdmD during pyroptosis and in diseases.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the role and mechanism of Gasdermin D (GsdmD) in the process of pyroptosis. Pyroptosis is an inflammatory form of cell death, and its main function is to combat microbial infections by inducing a strong inflammatory response. However, excessive pyroptosis can lead to various inflammatory diseases, such as sepsis and autoimmune diseases. The paper describes in detail the activation mechanism of GsdmD in pyroptosis, and how it releases inflammatory cytokines (such as IL - 1β and IL - 18) by forming transmembrane pores, thereby leading to cell death and inflammatory response. In addition, the paper also discusses the potential application of GsdmD as a pyroptosis effector in disease treatment, especially as a target for the treatment of inflammatory diseases. Specifically, the paper focuses on the following aspects: 1. **Structure and function of GsdmD**: GsdmD consists of a 31 - kDa N - terminus (GsdmD - N) and a 22 - kDa C - terminus (GsdmD - C), which are connected by a peptide chain. When activated, the peptide chain is cleaved, and GsdmD - N is separated from its inhibitory domain GsdmD - C to form transmembrane pores, resulting in the release of cell contents and cell death. 2. **Pathways of pyroptosis**: The paper introduces two main pyroptosis pathways - the classical pathway and the non - classical pathway. The classical pathway is initiated by recognizing pathogen - associated molecular patterns (PAMPs) and damage - associated molecular patterns (DAMPs), while the non - classical pathway is initiated by recognizing lipopolysaccharide (LPS) of Gram - negative bacteria. In both pathways, GsdmD is a downstream effector. 3. **Role of GsdmD in diseases**: The paper discusses the role of GsdmD in various diseases, including sepsis, Alzheimer's disease, human immunodeficiency virus (HIV) infection, and gout. In these diseases, excessive activation of pyroptosis may lead to pathological inflammatory responses. 4. **Development of GsdmD inhibitors**: Due to the crucial role of GsdmD in pyroptosis, the paper also mentions the development of inhibitors targeting GsdmD, which may become a new strategy for the treatment of inflammatory diseases. In summary, this paper aims to comprehensively analyze the mechanism of action of GsdmD in pyroptosis and explore its potential application in disease treatment.

Gasdermin D in pyroptosis

Research Progresses of Molecular Mechanism of Pyroptosis and Its Related Diseases

Gasdermin D:The killer protein performs cell pyroptosis

Pyroptosis: Gasdermin-Mediated Programmed Necrotic Cell Death

Gasdermin D-mediated pyroptosis: mechanisms, diseases, and inhibitors

Research Progress in Gasdermin Family Proteins and Their Association with Diseases

The gasdermin family: emerging therapeutic targets in diseases

Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death

Role of Pyroptosis in Inflammatory Bowel Disease (IBD): From Gasdermins to DAMPs

The gasdermins, a protein family executing cell death and inflammation

Pyroptosis, inflammasome, and gasdermins in tumor immunity

New insights into Gasdermin D pore formation

Gasdermins: a dual role in pyroptosis and tumor immunity

GSDMD membrane pore formation constitutes the mechanism of pyroptotic cell death

Pore formation by GSDMD is the effector mechanism of pyroptosis

Pyroptosis-induced inflammation and tissue damage

Gasdermins as evolutionarily conserved executors of inflammation and cell death

GSDMB promotes non-canonical pyroptosis by enhancing caspase-4 activity.

Molecular mechanism of pyroptosis and inflammasome activation

Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores

Pore-forming activity and structural autoinhibition of the gasdermin family